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Abstract
Bacterial resistance to antimicrobial therapies is an increasing clinical problem. This is as true for topical applications
as it is for systemic therapy. Topically, copper ions may be effective and cheap antimicrobials that act through multiple
pathways thereby limiting opportunities to bacteria for resistance. However, the chemistry of copper does not lend
itself to facile formulations that will readily release copper ions at biologically compatible pHs. Here, we have
developed nanoparticulate copper hydroxide adipate tartrate (CHAT) as a cheap, safe, and readily synthesised
material that should enable antimicrobial copper ion release in an infected wound environment.
First, we synthesised CHAT and showed that this had disperse aquated particle sizes of 2–5 nm and a mean
zeta potential of − 40 mV. Next, when diluted into bacterial medium, CHAT demonstrated similar efficacy to
copper chloride against Escherichia coli and Staphylococcus aureus, with dose-dependent activity occurring
mostly around 12.5–50 mg/L of copper. Indeed, at these levels, CHAT very rapidly dissolved and, as confirmed
by a bacterial copper biosensor, showed identical intracellular loading to copper ions derived from copper
chloride. However, when formulated at 250 mg/L in a topically applied matrix, namely hydroxyethyl cellulose,
the benefit of CHAT over copper chloride was apparent. The former yielded rapid sustained release of copper
within the bactericidal range, but the copper chloride, which formed insoluble precipitates at such concentration and
pH, achieved a maximum release of 10 ± 7 mg/L copper by 24 h.
We provide a practical formulation for topical copper-based antimicrobial therapy. Further studies, especially in vivo,
are merited.
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Background
Microbial infections contribute to millions of deaths glo-
bally [1]. Often, the inefficiency of an antimicrobial
treatment is due to microbial resistance to conventional
antibiotics [2–5]. As such, novel antimicrobials are
eagerly sought. Copper has long been recognised for its
antimicrobial effects and may have the potential for
greater clinical longevity than standard antibiotics since
it appears to act via a multiplicity of mechanisms against
bacteria, including interaction with bacterial proteins
and DNA, production of reactive oxygen species (ROS),
and disruption of membrane integrity [6, 7]. For the
same reason, it is suggested that the potential for anti-
microbial resistance of pathogenic bacterial strains to
copper and other metals is limited [7–9]. In addition,
copper is relatively cheap and is of low toxicity to
humans since its essentiality at trace levels has ensured
the evolution of tight homeostatic control [10–12].
There is, therefore, common use of this metal for pre-
ventative infection measures, mostly to avoid bacterial
biofilm formation on surfaces in high-risk areas such as
hospitals and nursing homes [13, 14]. In contrast, copper
has not found significant therapeutic use in topical anti-
microbial formulations, unlike silver which is widely
employed [15].
Bacteria are susceptible to copper loading in their
intracellular environment, and the effectiveness of a cop-
per source is related to its ability to release copper ions
[16, 17]. In this respect, a significant challenge for
copper-based antimicrobials is the achievement of a
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concentrated formulation that allows the sustained re-
lease of antimicrobial copper at effective concentrations
into fluids such as wound exudate. This is because cop-
per is a hydrolytic metal ion and as its concentration is
increased at the pH of typical topical formulations (i.e.
near neutral), so does its tendency to induce hydrolysis
and form insoluble oxo-hydroxides [18]. At physiological
pHs, these oxo-hydroxides are not good substrates for
the release of soluble or, therefore, potentially effica-
cious, copper ions [16, 19, 20].
Recently, with the purpose of finding a bioavailable
iron supplement, the issue of effective release of ferric
ions from a concentrated oxo-hydroxide source under
physiological conditions was solved through structural
modification of the primary particles. In that work, iron
was precipitated in the presence of crystal-doping GRAS
ligands, namely adipic and tartaric acids, to purposefully
destabilise the final ferric oxo-hydroxide structure. This
strategy had the advantage of (a) preventing irreversible
agglomeration of the ferric oxo-hydroxide particles and
(b) greatly increasing their lability (ease of solubility)
under appropriate physiological conditions. This mater-
ial has been termed “iron [oxo-]hydroxide adipate tar-
trate” or IHAT [21, 22]. By analogy, we considered here
whether copper [oxo-]hydroxide adipate tartrate
(CHAT) could be synthesised and formulated at high
concentrations but still release copper ions at effective
antimicrobial levels. In particular, the aim of this work
was to develop a cheap and scalable synthetic process
that produces copper oxo-hydroxide nanoparticles that,
unlike previously reported materials, should readily re-
lease biocidal concentrations of copper ions in a simu-
lated wound environment.
Thus, in this study, we synthesised CHAT and charac-
terised its ability to deliver bioavailable copper and,
hence, to demonstrate antimicrobial activity. We have
concentrated on strains of Escherichia coli as “indicator”
species for Gram-negative bacteria [19, 23] but have
additionally demonstrated proof-of-principle effects
against Staphylococcus aureus, as Gram-positive bacteria
that often obtain multidrug resistance. Hence, the study
aimed to assess the value of developing CHAT further
for clinical applications in topical antimicrobial therapy.
Methods
Unless otherwise stated, all experiments were
performed using ultra-high purity (UHP) water (re-
verse osmosis purification; 18.2 ΩM/cm), at room
temperature (20 ± 2 °C), and all reagents were pur-
chased from Sigma Aldrich.
Copper Formulations and CHAT Nanoparticles
Copper chloride stocks (40 mM copper) were prepared
by dissolving CuCl2·2H2O in water. Copper oxide
nanoparticle (CuO NPs; Sigma 544868) stocks were pre-
pared from a commercial powder that was free of im-
purities, had a primary particle size of 34 nm (range 10–
50 nm), and was previously tested as an antimicrobial
agent [24–26]. These stocks were prepared at 1.3 g/L
copper by dispersing the powder in water with vigorous
agitation. Colloidal suspensions of CHAT nanoparticles
were synthesised using a co-precipitation method [27].
Briefly, copper chloride, tartaric acid, and adipic acid
were dissolved in water to achieve a molar ratio of cop-
per/tartaric acid/adipic acid in the final suspension of 2:
1:1 and a copper concentration of 2.5 g/L. The initial pH
of the mixture was always below 2.5, and the copper was
fully solubilised. The pH was then slowly increased by a
drop-wise addition of a concentrated solution of NaOH
(5 M) with constant agitation until pH 8.2 ± 0.2.
Copper Content and Phase Distribution of CHAT
Suspensions
Copper content in colloidal suspensions was determined
by inductively coupled plasma-optical emission spec-
trometry (ICP-OES, Jobin Yvon 2000, Horiba). All sam-
ples were diluted down to concentrations below 100 mg/
L in 5% HNO3 (v/v) at least 24 h prior to analysis to en-
sure full solubility of copper. Calibration standards (0.1
to 100 mg/L copper) were matrix-matched in 5% HNO3,
and copper quantification was carried out at 324.
754 nm. Fractionation of the copper into percentages of
agglomerated, nanoparticulate, and soluble copper was
achieved by filtration and ultrafiltration of CHAT stocks.
Suspensions were filtered (200 nm cut-off ), and the
retentate was considered as the agglomerated fraction.
In order to isolate the soluble copper and to distinguish
it from nanoparticulate copper, the colloidal suspension
was ultrafiltered through a 3-KDa filter (Sartorius Vivas-
pin 500 VS0192; 16,000×g, 5 min) as this corresponds to
a cut-off below 1 nm (Zetasizer Software 7.11, Malvern
Instruments Ltd). The copper content of all fractions
(total, 200 nm filtrate, 3 KDa ultrafiltrate) was deter-
mined by ICP-OES, and fractions expressed as percent-
age in relation to total copper content are as follows:
%Soluble Copper < 1nmð Þ% ¼ Cu3KDa
CuTotal
 100
%Agglomerated Copper ¼ CuTotal−Cu<200nm
CuTotal
 100
%Nanoparticulate Copper ¼ 100−%Agglomerated copper
−%Soluble copper
Determination of Copper Content and Copper to Ligand
Ratios in Dry CHAT Nanoparticles
CHAT nanoparticles were agglomerated and precipitated
to enable recovery and removal of unbound components.
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To enable this, ethanol was added to colloidal suspensions
of CHAT (2.5 g/L copper) at a ratio of 2:1 ethanol/suspen-
sion (v/v), and the resulting CHAT agglomerates were re-
covered by centrifugation (4500×g × 15 min in a Mistral
6000). The solution phase, containing unbound ligand
species, was discarded. Determination of copper content
in solid-phase CHAT was as follows. A powder was pro-
duced by oven-drying the ethanolic precipitated pellet to
constant weight at 45 °C. This was then milled and 35.2 ±
0.3 mg (n = 2) was digested in 11 ± 1 g of 70% HNO3, with
accurate weights recorded. Once fully digested, this solu-
tion was diluted 20-fold in water and the copper concen-
tration determined by ICP-OES. Ligand to copper ratios
were determined directly from dried, ethanol-precipitated
CHAT agglomerates. The agglomerates were first re-
suspended in water to their original volume to facilitate
dissolution with lower amounts of HCl—a requirement
for high-performance liquid chromatography (HPLC) ana-
lysis. Aliquots were either dissolved in 5% HNO3 for ICP-
OES analysis of copper (as described above) or in 80 mM
HCl for HPLC analysis of ligands (tartaric and adipic
acids). Ligand analysis was carried out in a standard
reverse phase chromatography system (C18 column in a
Waters Alliance 2690/5 equipped with a 2998 PDA
detector; further details are given in Additional file 1).
Physicochemical Characterisation of CHAT Suspensions
Hydrodynamic particle size distribution was determined
by dynamic light scattering (DLS; Zetasizer NanoZS,
Malvern Instruments Ltd). Aliquots of CHAT colloidal
suspensions (2.5 g/L copper) were transferred to a 1-mL
disposable cuvette, and measurements (n = 3) were
carried out at 25 ± 2 °C. Again, the exact settings are
shown in Additional file 2. The zeta potential of CHAT
suspensions was determined by laser Doppler micro-
electrophoresis (Zetasizer NanoZS, Malvern Instruments
Ltd) using disposable folded capillary cells (DTS1070)
and assuming a dielectric constant of 78.5 and a viscos-
ity of 0.89 cP. Transmission electron microscopy (TEM)
characterisation was carried out applying a droplet of
CHAT suspension to holey carbon perforated grids
and drying at 50 °C overnight. Grids were then im-
aged on the TEM (FEI-Philips CM100) at 120 kV in
bright-field mode.
Antimicrobial Activity of Copper Formulations
Assays were carried out in heavy metal MOPS (HMM)
medium, a recognised metal-ion compatible medium
(Additional file 3), which was supplemented with 0.4%
glucose and 0.1% casein acid hydrolysate, and pH
adjusted to 7.2 ± 0.2 [28]. Prior to the addition of copper
compounds, Escherichia coli (NCTC11100) and
Staphylococcus aureus RN4220 [29] were grown over-
night at 30 °C under constant shaking in an Infors HT
Minitron incubator at 80 rpm. Afterwards, the bacterial
suspensions were diluted to an optical density of 0.05–0.
1 (ca. 106 cells/mL) at 595 nm for E. coli (Multiskan RC
351 Labsystem) or 600 nm for S. aureus (Multiskan
plate reader, ThermoFisher Scientific). Next, stocks of
copper chloride and colloidal CHAT were diluted in
HMM and added to the bacterial suspensions to obtain
final copper concentrations between 0.4 and 100 mg/L.
Incubation then took place for a period of 6 to 9 h, and
bacterial growth was determined by monitoring optical
density as a measure of bacterial biomass.
Copper solubility over time in bacterial growth
medium was determined by diluting copper chloride and
colloidal CHAT stocks in HMM to 12.5, 25, and 50 mg/
L copper and determining the fraction of soluble copper
at 0, 2, 4, and 8 h through ultrafiltration (3 KDa) and
ICP-OES analysis, as described above.
Intracellular Bioavailability of Copper Formulations
Recombinant bioluminescent Cu-sensing bacteria, E. coli
MC1061 (pSLcueR/pDNPcopAlux), which respond to
sub-toxic amounts of bioavailable copper by increasing
their bioluminescence were used to quantify the bio-
availability of copper compounds [30]. Bacterial suspen-
sions were prepared as described for the antimicrobial
activity assay and incubated with a series of dilutions of
copper chloride and CHAT (0 to 50 mg/L copper) on
96-well microplates for 4 h. Bioluminescence was
measured with an Orion II Plate Luminometer (Berthold
Detection Systems), and induction of bioluminescence
was calculated as follows:
Bioluminescence induction; Fold Change ¼ Bioluminescence in Cu exposure
Bioluminescence without Cu
Intracellular Stress Induced by Copper Formulations
The ability of copper compounds to induce intracellular
superoxide anions and single-strand DNA breaks was
assessed with recombinant bioluminescent bacteria, E.
coli K12::soxRSsodAlux and E. coli MC1061 (pDEWre-
cAlux), respectively [17]. Bacterial cultures were pre-
pared as described for the antimicrobial assay, and
bacteria were exposed to a series of dilutions of copper
chloride and CHAT (0 to 50 mg/L copper) on white 96-
well microplates over 4 h. The biosensors’ performances
were controlled by exposing bacteria to the superoxide
anion-inducing chemical menadione (0.04–30 μg/L), or
to hydrogen peroxide (0.1–150 mg/L), as positive con-
trols for E. coli K12::soxRSsodAlux or E. coli MC1061
(pDEWrecAlux), respectively. Again, bacteria were incu-
bated on white 96-well microplates and bioluminescence
was measured with an Orion II Plate Luminometer and
induction of bioluminescence was calculated as in Eq. 5.
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Incorporation of Copper Formulations in Hydroxyethyl
Cellulose Gels
Stocks of copper chloride, CHAT, and commercial, un-
modified copper oxide nanoparticles (CuO NPs) were
diluted in UHP water to 250 mg/L copper. The resulting
suspensions of CHAT and CuO NPs were at near neutral
pH and could be incorporated directly in the gel, but
copper chloride solution was still acidic after dilution
and was therefore adjusted to pH 7.0 ± 0.2. Hydro-
xyethylcellulose (HEC) was then dissolved directly (2%
w/v) into the various diluted stocks using a roller mixer
(Denley Spiramix 5) until homogenous gels were formed.
Ten grams of each gel was transferred into Falcon tubes
and allowed to settle overnight. Next, 10 mL of freshly
prepared 50 mM sodium bicarbonate buffer (dissolved
from NaHCO3 powder and adjusted to pH 7.0 ± 0.2) was
transferred into each tube with care to minimise distur-
bances at the gel-liquid interface (specific surface area of
7.1 cm2). Aliquots were then collected and analysed by
ICP-OES to determine copper release over time.
Results
As described in the “Methods” section, CHAT was synthe-
sised in a similar fashion to its iron analogue, IHAT [21,
22], by doping copper oxo-hydroxide (2.5 g/L copper)
with tartaric and adipic acids. This produced stable col-
loidal suspensions in which all copper went through a
200-nm filter but very little (5%) passed a 3-KDa filter.
This indicated that most copper was nanoparticulate
(95%; Fig. 1a) with little “free” copper and no detectable
large agglomerates—again like the IHAT analogue [21,
22]. When precipitated in ethanol, to remove unbound
ligand species, and then dried, CHAT contained 31 ± 1%
copper (w/w) by ICP-OES analysis. Copper to ligand
molar ratios, the latter determined by HPLC, were 2:1 for
copper to tartrate and 2:0.3 for copper to adipate. CHAT
particles appeared almost monodisperse with diameters of
2–3 nm by TEM imaging (Fig. 1b). These findings were
consistent with hydrodynamic sizing data for CHAT plus
a hydration shell since the median diameter by volume in
UHP water was 3.4 nm (Fig. 1c) and the size distribution
was narrow (2.4–5.6 nm for 80% of the volume) when
assessed with dynamic light scattering. The average zeta
potential was − 39 mV (Fig. 1d), consistent with the nano-
particles that form a stable aquated dispersion [27], and,
indeed, the CHAT stock suspension was shown to be
stable for several years (Additional file 4).
Next, we considered the antimicrobial activity of CHAT
when stock suspensions were diluted in bacterial growth
media to concentrations associated with the antimicrobial
activity of copper salts. For CHAT and copper chloride,
the growth inhibition curve was very similar for both E.
coli and S. aureus with most activity occurring at total
copper concentrations between the 12.5 and 50 mg/L
range (Fig. 2). Complete E. coli growth inhibition was ob-
served upon incubation with 18.8 (CuCl2) and 25 (CHAT)
mg/L copper, whilst for S. aureus, full growth inhibition
was obtained at 75 (CuCl2) and 100 (CHAT) mg/L copper
Fig. 1 Characterisation of CHAT stock solution. a Copper phase distribution at 2.5 g/L CHAT: soluble (< 3 KDa) and nanoparticulate percentage. b
Nanoparticle dispersion imaging by TEM. c Hydrodynamic particle size distribution of freshly prepared particles, as determined by dynamic light
scattering. d Zeta potential distribution (n = 3; error bars represent standard deviations)
Bastos et al. Nanoscale Research Letters  (2018) 13:111 Page 4 of 8
(Fig. 2; Percentage growth inhibition vs copper concentra-
tion is provided in Additional file 5).
Indeed, at these antimicrobial concentrations, at least
94% of CHAT was rapidly solubilised (within 15 min),
again as judged by ultrafiltration and ICP-OES analysis
(Fig. 3a). We therefore anticipated that the antimicrobial
effectiveness of CHAT was linked to this chemical labil-
ity, with rapid dissolution of the nanoparticles allowing
intracellular bacterial acquisition of copper ions. To test
this, we challenged the Cu-sensing E. coli, MC1061
(pSLcueR/pDNPcopAlux), in which bioluminescence in-
creases in response to sub-toxic concentrations of intra-
cellular copper ions [30], with 0 to 50 mg/L copper as
CHAT or copper chloride. Increasing concentrations in
the culture medium of both sources of copper led to in-
creasing bioluminescence in the E. coli copper sensor
strain (Fig. 3b), consistent with rises in intracellular cop-
per. The slope of the dose-response curve was identical
up to 6.25 mg/L for both sources of copper confirming
that bioavailable copper from CHAT was comparable to
a fully solubilised source. Thereafter, at concentrations
up to 50 mg/L copper, the luminescence did not increase
due to the toxicity of both copper compounds (Fig. 3b).
In parallel to studying intracellular copper in E. coli
exposed to solutions prepared with CHAT or copper
chloride, we also tested the ability of these solutions to
trigger intracellular superoxide anions or to cause
bacterial DNA damage in different E. coli-based biosen-
sors. In neither case was there a significantly observable
effect, despite the sensors responding to relevant positive
controls, namely hydrogen peroxide and menadione,
respectively (Fig. 3c, d). Taken together, the equivalent
responses of the three bacterial biosensors to solutions
prepared from different chemical forms of copper
strongly support the notion that, in both cases, bacteria
were being exposed to the same soluble copper, in spite
of one formulation starting out as nanoparticulate.
Finally, as noted above, the advantage of CHAT over
soluble copper salts would only be apparent if a concen-
trated formulation allowed the former to retain its
chemical lability unlike the latter. Using hydroxyethyl
cellulose (HEC), a common aqueous base for topical for-
mulations [31–33], we incorporated 250 mg/L copper as
either copper chloride, CHAT, or as the commercial
CuO NPs. When 10 mL of 50 mM NaHCO3 buffer, as a
simplified wound exudate, were added to 10 g of each of
the copper-incorporated HEC gels (i.e. 2.5 mg copper),
there was sustained release of copper from the CHAT-
containing preparation, to greater than 60 mg/L by 24 h
(Fig. 4). Moreover, release was relatively rapid with anti-
microbially active concentrations being achieved by 2–
4 h. In contrast, pH-neutralised copper chloride was a
poor substrate for copper release, as anticipated by its
tendency to hydrolyse and form agglomerates of copper
Fig. 2 Escherichia coli (top) and Staphylococcus aureus (bottom) growth curves, represented here as optical density, upon exposure to different
concentrations of copper chloride (left) or CHAT (right) in supplemented HMM.
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oxo-hydroxides, so by 24 h, only 10 ± 7 mg/L copper
had been achieved in solution (Fig. 4). The commer-
cial CuO NPs yielded no discernible copper release at
all (Fig. 4).
Discussion
We show here that a copper-based nanomaterial, namely
CHAT, can be formulated at high concentrations, unlike
previously described copper-based nanoparticles [34, 35],
whilst retaining its properties as a labile source of bioavail-
able copper with antimicrobial efficacy. As noted above,
the synthesis of CHAT was inspired following many years’
previous work on the iron analogue, IHAT [21, 22]. This,
in turn, was inspired by nature’s solution to rapid mineral
turnover in vivo, for the efficient recycling of essential
metal ions, whereby organic molecules are used to desta-
bilise the crystal structure of primary mineral particles
[21, 22]. In the synthetic versions, GRAS ligands are in-
corporated into metal oxo-hydroxides as they form in so-
lution from cross-linking polymers [21, 22]. Through
structural destabilisation, this ensures lability of the final
mineral phase and also generates highly negative nanopar-
ticles—as demonstrated by the zeta potential measure-
ment—which repel agglomeration and aggregation, thus
producing nanoparticle suspensions that were stable for
years. Here, and as previously shown for IHAT, tartrate
was the dominant ligand in achieving these physicochemi-
cal changes to the copper oxo-hydroxide structure since
its incorporation was ca. 3-fold greater than that of
adipate—the latter behaving more so as a buffer during
synthesis [21, 22].
In the absence of modification, freshly precipitated
metal oxo-hydroxides will agglomerate and aggregate
and will start to age, whereby they condense and grad-
ually increase their crystallinity. These size and mineral
phase transitions reduce the ability of the structures to
Fig. 3 a Dissolution profile of CHAT in supplemented HMM at 12.5, 25, and 50 mg/L copper. Dose-response of bioluminescence induction of
recombinant luminescent bacteria: b intracellular copper ion-responding E. coli MC1061 pSLcueR/pDNPcopAlux bacteria, c DNA damage-responding
E. coli MC1061 (pDEWrecAlux), and d superoxide anion-responding E. coli K12::soxRSsodAlux upon exposure for 4 h in supplemented HMM to copper
chloride, CHAT (concentration in mg Cu/L), and respective controls (menadione in c and H2O2 in d)
Fig. 4 Copper release from HEC matrices containing CHAT, copper
chloride, or copper oxide nanoparticles (CuO NPs), all at 250 mg/L copper
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participate in the reverse reaction, i.e. to re-dissolve. It
was therefore unsurprising that when copper oxo-
hydroxide was freshly formed, from pH neutralisation of
a copper chloride solution, at least some soluble copper
was released in our gel release assay (Fig. 4), whereas for
the commercial CuO NPs, which were agglomerated and
comprised a more condensed mineral phase (i.e. copper
oxide), undetectable copper was released. The lack of
dissolution from commercial 30 nm nanoparticles—
which, regardless of their aggregation state, would have
presented a large surface area for dissolution—shows
that mineral phase is a key driver in the release of cop-
per ions and that, as noted above, modification of the
mineral’s primary particles, achieved here through ligand
doping, is really required to bring about a marked shift
in dissolution characteristics. Furthermore, the synthesis
of CHAT was carried out at room temperature, since
high synthetic temperature favours less amorphous
phases which consequently may reduce dissolution rates.
Also, room temperature synthesis has the benefit of re-
ducing energetic costs when manufacturing at scale.
Whilst there may be other ways to formulate high,
stable concentrations of copper that enables sustained
release and rapid dissolution of ions when required, we
cannot envisage another synthesis that is so straightfor-
ward and the cost of goods (for reactants) so low. These
are important factors as the issue of topical infections
and bacterial resistance are by no means restricted to
developed countries. Developing countries are increas-
ingly plagued by bacterial resistance issues and so afford-
able efficacious solutions are urgently required [36, 37].
Although there are insufficient studies to reach concrete
solutions, there is evidence that resistance to toxic metal
ions is more difficult for bacteria to achieve than resist-
ance to conventional antibiotics [7]. The theory is predi-
cated on the idea that copper and silver probably do not
have discrete pathways of antimicrobial activity but, ra-
ther, can impact multiple targets including various en-
zyme systems and thus can destabilise the overall
bacterial cell structure [17, 19, 38]. Indeed, it has been
shown that bacteria remain susceptible to copper and
certain other metals ions in spite of exposures over cen-
turies [6, 7, 39]. Interestingly, there is recent evidence
that metal-based antimicrobials can even return bacterial
sensitivity to conventional antibiotics in spite of prior
resistance [40, 41].
Conclusions
Here, we have demonstrated that the issue of bioavail-
able copper ions, at physiological pHs and high concen-
trations, can be solved by doping a copper nanomineral
with organic acids, in a similar strategy to that previ-
ously utilised for iron analogues [21, 22]. These copper-
based nanoparticles (termed CHAT) readily dissolved in
the bacterial medium, showing equivalent intracellular
copper uptake and antibacterial activity to soluble cop-
per salts. Critically, however, and unlike for simple cop-
per salts, CHAT can be concentrated in a pH-neutral
formulation and retain its lability in terms of copper ion
release. Indeed, CHAT released copper ions within the
bactericidal range and could thus be the basis for a
novel, topical antimicrobial agent either alone or enhan-
cing the efficacy of resisting antibiotics. With increasing
antibiotic resistance, new topical antimicrobials are
needed and CHAT is inexpensive, readily synthesised,
and uses components that are generally recognised as
safe (GRAS). In vivo studies are merited.
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